A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial

A randomized, placebo-controlled trial on a firstchoice combined oral contraceptive found decreased general well-being but no statistically significant effect on depressive symptoms in healthy women.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment

Volume 107, Issue 5, Pages 1238–1245

Authors:

Niklas Zethraeus, Ph.D., Anna Dreber, Ph.D., Eva Ranehill, Ph.D., Liselott Blomberg, B.Sc., Fernand Labrie, M.D., Ph.D., Bo von Schoultz, M.D., Ph.D., Magnus Johannesson, Ph.D., Angelica Lindén Hirschberg, M.D., Ph.D.

Abstract:

This study demonstrates a statistically significant reduction in general well-being by a first-choice OC in comparison with placebo in healthy women. We found no statistically significant effects on depressive symptoms. A reduction in general well-being should be of clinical importance.


Read the full text here.

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.